BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 448 hits Enz. Inhib. hit(s) with Target = 'Adenylate cyclase'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Adenylate cyclase


(Homo sapiens (Human))
BDBM50051588
PNG
(CHEMBL429362 | His-Ser-Gln-thr-Phe-Thr-Ser-Asp-Tyr...)
Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)Cc1c[nH]cn1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
Show InChI InChI=1S/C153H225N43O49S/c1-72(2)52-97(133(226)176-96(47-51-246-11)132(225)184-104(60-115(159)209)143(236)196-123(78(10)203)151(244)245)179-137(230)103(58-83-64-167-89-29-19-18-28-87(83)89)183-131(224)95(43-46-114(158)208)177-148(241)120(74(5)6)194-141(234)101(54-79-24-14-12-15-25-79)182-138(231)105(61-117(211)212)185-130(223)94(42-45-113(157)207)171-124(217)75(7)170-127(220)91(31-22-49-165-152(160)161)172-128(221)92(32-23-50-166-153(162)163)174-146(239)110(69-199)191-140(233)107(63-119(215)216)186-134(227)98(53-73(3)4)178-135(228)99(56-81-33-37-85(204)38-34-81)180-129(222)90(30-20-21-48-154)173-145(238)109(68-198)190-136(229)100(57-82-35-39-86(205)40-36-82)181-139(232)106(62-118(213)214)187-147(240)111(70-200)192-150(243)122(77(9)202)195-142(235)102(55-80-26-16-13-17-27-80)188-149(242)121(76(8)201)193-116(210)66-168-126(219)93(41-44-112(156)206)175-144(237)108(67-197)189-125(218)88(155)59-84-65-164-71-169-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,167,197-205H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H,164,169)(H,168,219)(H,170,220)(H,171,217)(H,172,221)(H,173,238)(H,174,239)(H,175,237)(H,176,226)(H,177,241)(H,178,228)(H,179,230)(H,180,222)(H,181,232)(H,182,231)(H,183,224)(H,184,225)(H,185,223)(H,186,227)(H,187,240)(H,188,242)(H,189,218)(H,190,229)(H,191,233)(H,192,243)(H,193,210)(H,194,234)(H,195,235)(H,196,236)(H,211,212)(H,213,214)(H,215,216)(H,244,245)(H4,160,161,165)(H4,162,163,166)/t75-,76-,77-,78+,88+,90-,91-,92-,93+,94-,95-,96-,97-,98-,99-,100+,101-,102+,103-,104-,105-,106+,107-,108+,109-,110-,111+,120-,121+,122+,123-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 8n/an/an/an/a



University of Arizona

Curated by ChEMBL


Assay Description
Ability of the Compound to activate Adenylate cyclase activity was measured by the conversion of [alpha-32P]ATP to 3'5'-cyclic AMP


J Med Chem 39: 2449-55 (1996)


Article DOI: 10.1021/jm960130b
BindingDB Entry DOI: 10.7270/Q2JH3MT3
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50010684
PNG
((6aR,12bS)-6-Propyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Show SMILES CCCN1Cc2ccccc2[C@H]2[C@H]1CCc1cc(O)c(O)cc21
Show InChI InChI=1S/C20H23NO2/c1-2-9-21-12-14-5-3-4-6-15(14)20-16-11-19(23)18(22)10-13(16)7-8-17(20)21/h3-6,10-11,17,20,22-23H,2,7-9,12H2,1H3/t17-,20-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>10n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032519
PNG
((6aR,12bS)-2-Phenyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Show SMILES Oc1cc2CC[C@H]3NCc4ccc(cc4[C@@H]3c2cc1O)-c1ccccc1
Show InChI InChI=1S/C23H21NO2/c25-21-11-16-8-9-20-23(19(16)12-22(21)26)18-10-15(6-7-17(18)13-24-20)14-4-2-1-3-5-14/h1-7,10-12,20,23-26H,8-9,13H2/t20-,23-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 10n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032518
PNG
((6aR,12bS)-3-Methyl-6-propyl-5,6,6a,7,8,12b-hexahy...)
Show SMILES CCCN1Cc2cc(C)ccc2[C@H]2[C@H]1CCc1cc(O)c(O)cc21
Show InChI InChI=1S/C21H25NO2/c1-3-8-22-12-15-9-13(2)4-6-16(15)21-17-11-20(24)19(23)10-14(17)5-7-18(21)22/h4,6,9-11,18,21,23-24H,3,5,7-8,12H2,1-2H3/t18-,21-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 10n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase


(Rattus norvegicus)
BDBM50004822
PNG
((R)-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine...)
Show SMILES Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O
Show InChI InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2/t14-/m1/s1
Reactome pathway

UniProtKB/TrEMBL

GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 32n/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Inhibition of Rap1A-mediated geranylgeranylation expressed in mouse NIH3T3 cells


J Med Chem 25: 697-703 (1982)


Article DOI: 10.1021/jm00348a017
BindingDB Entry DOI: 10.7270/Q2154K7B
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50010686
PNG
((6aR,12bS)-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydr...)
Show SMILES Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O
Show InChI InChI=1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2/t14-,17-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 51n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Tested for effective dose agonist activity against adenylate cyclase in rat striatal membrane


J Med Chem 37: 2453-60 (1994)


Article DOI: 10.1021/jm00041a025
BindingDB Entry DOI: 10.7270/Q2KS6QKD
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50010686
PNG
((6aR,12bS)-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydr...)
Show SMILES Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O
Show InChI InChI=1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2/t14-,17-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 60n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound against adenylate cyclase


J Med Chem 37: 2453-60 (1994)


Article DOI: 10.1021/jm00041a025
BindingDB Entry DOI: 10.7270/Q2KS6QKD
More data for this
Ligand-Target Pair
Adenylate cyclase


(Rattus norvegicus)
BDBM50004923
PNG
((+/-)-SKF-38393 | 1-Phenyl-2,3,4,5-tetrahydro-1H-b...)
Show SMILES Oc1cc2CCNCC(c3ccccc3)c2cc1O
Show InChI InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2
Reactome pathway

UniProtKB/TrEMBL

GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 71n/an/an/an/a



TBA

Curated by ChEMBL


Assay Description
Inhibition of Rap1A-mediated geranylgeranylation expressed in mouse NIH3T3 cells


J Med Chem 25: 697-703 (1982)


Article DOI: 10.1021/jm00348a017
BindingDB Entry DOI: 10.7270/Q2154K7B
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50004822
PNG
((R)-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine...)
Show SMILES Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O
Show InChI InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2/t14-/m1/s1
PDB

Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
antibodypedia
antibodypedia
antibodypedia
antibodypedia
antibodypedia
antibodypedia
antibodypedia
antibodypedia
GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 71n/an/an/an/a



University of Lund

Curated by ChEMBL


Assay Description
Compound was tested for the adenylate cyclase stimulation


J Med Chem 35: 502-7 (1992)


Article DOI: 10.1021/jm00081a010
BindingDB Entry DOI: 10.7270/Q2TH8N95
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50004822
PNG
((R)-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine...)
Show SMILES Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O
Show InChI InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2/t14-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 80n/an/an/an/a



Royal Danish School of Pharmacy

Curated by ChEMBL


Assay Description
Effective concentration required to stimulate Adenylate cyclase


J Med Chem 33: 2197-204 (1990)


Article DOI: 10.1021/jm00170a025
BindingDB Entry DOI: 10.7270/Q2TD9XZB
More data for this
Ligand-Target Pair
Adenylate cyclase type 8


(Homo sapiens (Human))
BDBM50010261
PNG
((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10...)
Show SMILES CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1
Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
Purchase

CHEBI
CHEMBL
DrugBank
KEGG
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

PubMed
n/an/an/an/a 94n/an/an/an/a



Kunming Medical University

Curated by ChEMBL


Assay Description
Agonist activity at recombinant human AC8 expressed in human HEK293 cells assessed as fold increase in cAMP level by LANCE Ultra cAMP Detection kit m...


Bioorg Med Chem Lett 30: (2020)

More data for this
Ligand-Target Pair
Adenylate cyclase type 8


(Homo sapiens (Human))
BDBM50537925
PNG
(CHEMBL4644318)
Show SMILES CCOC(=O)C1(Cc2ccc(Cl)cc2Cl)C(=O)Nc2ccccc12
Show InChI InChI=1S/C18H15Cl2NO3/c1-2-24-17(23)18(10-11-7-8-12(19)9-14(11)20)13-5-3-4-6-15(13)21-16(18)22/h3-9H,2,10H2,1H3,(H,21,22)
Reactome pathway

UniProtKB/SwissProt
UniProtKB/TrEMBL

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
PubMed
n/an/an/an/a 105n/an/an/an/a



Kunming Medical University

Curated by ChEMBL


Assay Description
Agonist activity at recombinant human AC8 expressed in human HEK293 cells assessed as fold increase in cAMP level by LANCE Ultra cAMP Detection kit m...


Bioorg Med Chem Lett 30: (2020)

More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032522
PNG
((6aR,12bS)-2-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Show SMILES Cc1ccc2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3c2c1
Show InChI InChI=1S/C18H19NO2/c1-10-2-3-12-9-19-15-5-4-11-7-16(20)17(21)8-14(11)18(15)13(12)6-10/h2-3,6-8,15,18-21H,4-5,9H2,1H3/t15-,18-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 114n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032524
PNG
((6aR,12bS)-5,6,6a,7,8,12b-Hexahydro-benzo[a]phenan...)
Show SMILES Oc1ccc2[C@H]3[C@@H](CCc4cc(O)c(O)cc34)NCc2c1
Show InChI InChI=1S/C17H17NO3/c19-11-2-3-12-10(5-11)8-18-14-4-1-9-6-15(20)16(21)7-13(9)17(12)14/h2-3,5-7,14,17-21H,1,4,8H2/t14-,17-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 130n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032520
PNG
((6aR,12bS)-3-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Show SMILES Cc1ccc2[C@H]3[C@@H](CCc4cc(O)c(O)cc34)NCc2c1
Show InChI InChI=1S/C18H19NO2/c1-10-2-4-13-12(6-10)9-19-15-5-3-11-7-16(20)17(21)8-14(11)18(13)15/h2,4,6-8,15,18-21H,3,5,9H2,1H3/t15-,18-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 134n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50010686
PNG
((6aR,12bS)-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydr...)
Show SMILES Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O
Show InChI InChI=1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2/t14-,17-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 141n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032521
PNG
((6aR,12bS)-5,6,6a,7,8,12b-Hexahydro-benzo[a]phenan...)
Show SMILES Oc1ccc2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3c2c1
Show InChI InChI=1S/C17H17NO3/c19-11-3-1-10-8-18-14-4-2-9-5-15(20)16(21)7-13(9)17(14)12(10)6-11/h1,3,5-7,14,17-21H,2,4,8H2/t14-,17-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 148n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032523
PNG
((6aR,12bS)-4-Methyl-5,6,6a,7,8,12b-hexahydro-benzo...)
Show SMILES Cc1cccc2[C@H]3[C@@H](CCc4cc(O)c(O)cc34)NCc12
Show InChI InChI=1S/C18H19NO2/c1-10-3-2-4-12-14(10)9-19-15-6-5-11-7-16(20)17(21)8-13(11)18(12)15/h2-4,7-8,15,18-21H,5-6,9H2,1H3/t15-,18-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 151n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50010714
PNG
(1-p-Tolyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,...)
Show SMILES Cc1ccc(cc1)[C@H]1CNCCc2cc(O)c(O)cc12
Show InChI InChI=1S/C17H19NO2/c1-11-2-4-12(5-3-11)15-10-18-7-6-13-8-16(19)17(20)9-14(13)15/h2-5,8-9,15,18-20H,6-7,10H2,1H3/t15-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 210n/an/an/an/a



Royal Danish School of Pharmacy

Curated by ChEMBL


Assay Description
Effective concentration required to stimulate Adenylate cyclase


J Med Chem 33: 2197-204 (1990)


Article DOI: 10.1021/jm00170a025
BindingDB Entry DOI: 10.7270/Q2TD9XZB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50009854
PNG
(CHEMBL13078 | [1-(2-Morpholin-4-yl-ethyl)-1H-indol...)
Show SMILES O=C(c1cn(CCN2CCOCC2)c2ccccc12)c1cccc2ccccc12
Show InChI InChI=1S/C25H24N2O2/c28-25(22-10-5-7-19-6-1-2-8-20(19)22)23-18-27(24-11-4-3-9-21(23)24)13-12-26-14-16-29-17-15-26/h1-11,18H,12-17H2
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
Purchase

CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 275n/an/an/an/a



National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL


Assay Description
Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.


J Med Chem 39: 1967-74 (1996)


Article DOI: 10.1021/jm950932r
BindingDB Entry DOI: 10.7270/Q27M071B
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032516
PNG
((6aR,12bS)-4-Methyl-6-propyl-5,6,6a,7,8,12b-hexahy...)
Show SMILES CCCN1Cc2c(C)cccc2[C@H]2[C@H]1CCc1cc(O)c(O)cc21
Show InChI InChI=1S/C21H25NO2/c1-3-9-22-12-17-13(2)5-4-6-15(17)21-16-11-20(24)19(23)10-14(16)7-8-18(21)22/h4-6,10-11,18,21,23-24H,3,7-9,12H2,1-2H3/t18-,21-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 333n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50009864
PNG
(CHEMBL274833 | [2-Methyl-1-(2-morpholin-4-yl-ethyl...)
Show SMILES Cc1c(C(=O)c2cccc3ccccc23)c2ccccc2n1CCN1CCOCC1
Show InChI InChI=1S/C26H26N2O2/c1-19-25(26(29)22-11-6-8-20-7-2-3-9-21(20)22)23-10-4-5-12-24(23)28(19)14-13-27-15-17-30-18-16-27/h2-12H,13-18H2,1H3
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 370n/an/an/an/a



National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL


Assay Description
Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.


J Med Chem 39: 1967-74 (1996)


Article DOI: 10.1021/jm950932r
BindingDB Entry DOI: 10.7270/Q27M071B
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052140
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...)
Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCN2CCCCC2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C30H48N2O8/c1-8-27(5)18-21(35)30(37)28(6)20(34)12-13-26(3,4)23(28)22(24(38-19(2)33)29(30,7)40-27)39-25(36)31-14-17-32-15-10-9-11-16-32/h8,20,22-24,34,37H,1,9-18H2,2-7H3,(H,31,36)/t20-,22-,23-,24-,27-,28-,29+,30-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 500n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50010261
PNG
((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10...)
Show SMILES CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
Purchase

CHEBI
CHEMBL
DrugBank
KEGG
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 500n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052141
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-[2-...)
Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCc2ccc(N)cc2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C31H44N2O8/c1-8-28(5)17-22(36)31(38)29(6)21(35)13-15-27(3,4)24(29)23(25(39-18(2)34)30(31,7)41-28)40-26(37)33-16-14-19-9-11-20(32)12-10-19/h8-12,21,23-25,35,38H,1,13-17,32H2,2-7H3,(H,33,37)/t21-,23-,24-,25-,28-,29-,30+,31-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 500n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052150
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...)
Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCO)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C25H39NO9/c1-8-22(5)13-16(30)25(32)23(6)15(29)9-10-21(3,4)18(23)17(34-20(31)26-11-12-27)19(33-14(2)28)24(25,7)35-22/h8,15,17-19,27,29,32H,1,9-13H2,2-7H3,(H,26,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 500n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052137
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...)
Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCc2ccccn2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C30H42N2O8/c1-8-27(5)17-21(35)30(37)28(6)20(34)12-14-26(3,4)23(28)22(24(38-18(2)33)29(30,7)40-27)39-25(36)32-16-13-19-11-9-10-15-31-19/h8-11,15,20,22-24,34,37H,1,12-14,16-17H2,2-7H3,(H,32,36)/t20-,22-,23-,24-,27-,28-,29+,30-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 600n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50010274
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(2-...)
Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCN)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C25H40N2O8/c1-8-22(5)13-16(30)25(32)23(6)15(29)9-10-21(3,4)18(23)17(34-20(31)27-12-11-26)19(33-14(2)28)24(25,7)35-22/h8,15,17-19,29,32H,1,9-13,26H2,2-7H3,(H,27,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 600n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50032517
PNG
((6aR,12bS)-2-Ethyl-5,6,6a,7,8,12b-hexahydro-benzo[...)
Show SMILES CCc1ccc2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3c2c1
Show InChI InChI=1S/C19H21NO2/c1-2-11-3-4-13-10-20-16-6-5-12-8-17(21)18(22)9-15(12)19(16)14(13)7-11/h3-4,7-9,16,19-22H,2,5-6,10H2,1H3/t16-,19-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 610n/an/an/an/a



Purdue University

Curated by ChEMBL


Assay Description
Effective concentration of the compound as Adenylate cyclase activity was measured in rat homogenate


J Med Chem 38: 3062-70 (1995)


Article DOI: 10.1021/jm00016a009
BindingDB Entry DOI: 10.7270/Q2JD4VTB
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50010267
PNG
(CHEMBL92719 | [2-(4-Hydroxy-phenyl)-ethyl]-carbami...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccc(O)cc1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C29H41NO8/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(23(34)28(29,6)38-26)37-24(35)30-15-13-17-8-10-18(31)11-9-17/h7-11,19,21-23,31-32,34,36H,1,12-16H2,2-6H3,(H,30,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 630n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052124
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...)
Show SMILES COCCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C
Show InChI InChI=1S/C26H41NO9/c1-9-23(5)14-17(30)26(32)24(6)16(29)10-11-22(3,4)19(24)18(35-21(31)27-12-13-33-8)20(34-15(2)28)25(26,7)36-23/h9,16,18-20,29,32H,1,10-14H2,2-8H3,(H,27,31)/t16-,18-,19-,20-,23-,24-,25+,26-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 700n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50010268
PNG
((2-Amino-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,10...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCN)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C23H38N2O7/c1-7-20(4)12-14(27)23(30)21(5)13(26)8-9-19(2,3)16(21)15(28)17(22(23,6)32-20)31-18(29)25-11-10-24/h7,13,15-17,26,28,30H,1,8-12,24H2,2-6H3,(H,25,29)/t13-,15-,16-,17-,20-,21-,22+,23-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 700n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052117
PNG
(CHEMBL317534 | Cyclohexylmethyl-carbamic acid (3R,...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCC1CCCCC1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C28H45NO7/c1-7-25(4)15-19(31)28(34)26(5)18(30)13-14-24(2,3)21(26)20(22(32)27(28,6)36-25)35-23(33)29-16-17-11-9-8-10-12-17/h7,17-18,20-22,30,32,34H,1,8-16H2,2-6H3,(H,29,33)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.00E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase type V


(Rattus norvegicus)
BDBM50050489
PNG
(CHEMBL61448 | [6-Isothiocyanato-1-(2-morpholin-4-y...)
Show SMILES O=C(c1cn(CCN2CCOCC2)c2cc(ccc12)N=C=S)c1cccc2ccccc12
Show InChI InChI=1S/C26H23N3O2S/c30-26(23-7-3-5-19-4-1-2-6-21(19)23)24-17-29(11-10-28-12-14-31-15-13-28)25-16-20(27-18-32)8-9-22(24)25/h1-9,16-17H,10-15H2
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.10E+3n/an/an/an/a



National Institute of Diabetes and Digestive and Kidney Diseases

Curated by ChEMBL


Assay Description
Compound was evaluated for inhibition of hormone stimulated Adenylate cyclase activity in N18TG2 membranes.


J Med Chem 39: 1967-74 (1996)


Article DOI: 10.1021/jm950932r
BindingDB Entry DOI: 10.7270/Q27M071B
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052129
PNG
(CHEMBL93259 | Phenethyl-carbamic acid (3R,4aR,5S,6...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccccc1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C29H41NO7/c1-7-26(4)17-20(32)29(35)27(5)19(31)13-15-25(2,3)22(27)21(23(33)28(29,6)37-26)36-24(34)30-16-14-18-11-9-8-10-12-18/h7-12,19,21-23,31,33,35H,1,13-17H2,2-6H3,(H,30,34)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.10E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052143
PNG
(CHEMBL93242 | [2-(4-Amino-phenyl)-ethyl]-carbamic ...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccc(N)cc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C29H42N2O7/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(34)23(28(29,6)38-26)37-24(35)31-15-13-17-8-10-18(30)11-9-17/h7-11,19,21-23,32,34,36H,1,12-16,30H2,2-6H3,(H,31,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.10E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052130
PNG
((2-Pyridin-2-yl-ethyl)-carbamic acid (3R,4aR,5S,6S...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccccn1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C28H40N2O7/c1-7-25(4)16-19(32)28(35)26(5)18(31)11-13-24(2,3)21(26)20(33)22(27(28,6)37-25)36-23(34)30-15-12-17-10-8-9-14-29-17/h7-10,14,18,20-22,31,33,35H,1,11-13,15-16H2,2-6H3,(H,30,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.10E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052126
PNG
((2-Piperidin-1-yl-ethyl)-carbamic acid (3R,4aR,5S,...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCN1CCCCC1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C28H46N2O7/c1-7-25(4)17-19(32)28(35)26(5)18(31)11-12-24(2,3)21(26)20(33)22(27(28,6)37-25)36-23(34)29-13-16-30-14-9-8-10-15-30/h7,18,20-22,31,33,35H,1,8-17H2,2-6H3,(H,29,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.20E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052131
PNG
(CHEMBL93521 | Propyl-carbamic acid (3R,4aR,5S,6S,6...)
Show SMILES CCCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C24H39NO7/c1-8-12-25-19(29)31-18-16(28)17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(18,24)7/h9,14,16-18,26,28,30H,2,8,10-13H2,1,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 1.30E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50010269
PNG
(CHEMBL327672 | [2-(4-Hydroxy-phenyl)-ethyl]-carbam...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccc(O)cc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C29H41NO8/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(34)23(28(29,6)38-26)37-24(35)30-15-13-17-8-10-18(31)11-9-17/h7-11,19,21-23,31-32,34,36H,1,12-16H2,2-6H3,(H,30,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.40E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052142
PNG
((2-Hydroxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCO)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C23H37NO8/c1-7-20(4)12-14(27)23(30)21(5)13(26)8-9-19(2,3)16(21)15(28)17(22(23,6)32-20)31-18(29)24-10-11-25/h7,13,15-17,25-26,28,30H,1,8-12H2,2-6H3,(H,24,29)/t13-,15-,16-,17-,20-,21-,22+,23-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 1.40E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052123
PNG
(Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...)
Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCc2ccccc2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C31H43NO8/c1-8-28(5)18-22(35)31(37)29(6)21(34)14-16-27(3,4)24(29)23(25(38-19(2)33)30(31,7)40-28)39-26(36)32-17-15-20-12-10-9-11-13-20/h8-13,21,23-25,34,37H,1,14-18H2,2-7H3,(H,32,36)/t21-,23-,24-,25-,28-,29-,30+,31-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.50E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052113
PNG
((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...)
Show SMILES COCCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(28)18(23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.60E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052148
PNG
((2-Piperidin-1-yl-ethyl)-carbamic acid (3R,4aR,5S,...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCN1CCCCC1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C28H46N2O7/c1-7-25(4)17-19(32)28(35)26(5)18(31)11-12-24(2,3)21(26)20(22(33)27(28,6)37-25)36-23(34)29-13-16-30-14-9-8-10-15-30/h7,18,20-22,31,33,35H,1,8-17H2,2-6H3,(H,29,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.70E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052146
PNG
((2-Pyridin-2-yl-ethyl)-carbamic acid (3R,4aR,5S,6S...)
Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccccn1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C
Show InChI InChI=1S/C28H40N2O7/c1-7-25(4)16-19(32)28(35)26(5)18(31)11-13-24(2,3)21(26)20(22(33)27(28,6)37-25)36-23(34)30-15-12-17-10-8-9-14-29-17/h7-10,14,18,20-22,31,33,35H,1,11-13,15-16H2,2-6H3,(H,30,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.80E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052111
PNG
((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...)
Show SMILES COCCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C
Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(18(28)23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>2.00E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052112
PNG
((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...)
Show SMILES CC(C)(C)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(31)20(26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>2.00E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052136
PNG
(3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-Acetoxy-10,1...)
Show SMILES CCOC(=O)CCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C
Show InChI InChI=1S/C28H43NO10/c1-9-25(6)15-18(32)28(35)26(7)17(31)11-13-24(4,5)21(26)20(22(37-16(3)30)27(28,8)39-25)38-23(34)29-14-12-19(33)36-10-2/h9,17,20-22,31,35H,1,10-15H2,2-8H3,(H,29,34)/t17-,20-,21-,22-,25-,26-,27+,28-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>2.00E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052119
PNG
((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...)
Show SMILES CC(C)(C)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C
Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(20(31)26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>2.00E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Adenylate cyclase


(Homo sapiens (Human))
BDBM50052116
PNG
(CHEMBL93260 | Isobutyl-carbamic acid (3R,4aR,5S,6S...)
Show SMILES CC(C)CNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C
Show InChI InChI=1S/C25H41NO7/c1-9-22(6)12-16(28)25(31)23(7)15(27)10-11-21(4,5)18(23)17(29)19(24(25,8)33-22)32-20(30)26-13-14(2)3/h9,14-15,17-19,27,29,31H,1,10-13H2,2-8H3,(H,26,30)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1
NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a>2.00E+3n/an/an/an/a



Food and Drug Administration

Curated by ChEMBL


Assay Description
Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1


J Med Chem 39: 2745-52 (1996)


Article DOI: 10.1021/jm960191+
BindingDB Entry DOI: 10.7270/Q2X34WJG
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 448 total )  |  Next  |  Last  >>
Jump to: